News

The Christian Post on MSN9h
Trump's FDA head Marty Makary calls 'soul care' essential to health, warns spiritual needs often 'neglected'
President Donald Trump s newly confirmed Food and Drug Administration Commissioner, Dr Marty Makary, emphasized that soul ...
FDA Commissioner and Congress Speaking Same Language to Reduce Animal Testing in Drug Development
HHS Secretary Kennedy and FDA Commissioner Makary signal movement away from animal testing while a group of bipartisan ...
Long Island Press1d
Northwell Health clinical trial studies ability to treat depression with deep brain stimulation
Northwell Health is conducting a clinical trial to address treatment-resistant depression using deep brain stimulation.
Everyday Health on MSN2d
What Are the Benefits of Fish Oil for Depression?
There’s evidence that the omega-3 fatty acids in fish may help the brain, but more data is needed to know specifically if and ...
Postpartum Depression Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
The leading Postpartum Depression Companies such as GH Research, Reunion Neuroscience, Lipocine, Brii Biosciences Limited, ...
Discover Magazine on MSN8d
Linking Inflammation to Depression Could Yield More Targeted Treatment
Animal studies could lead to blood tests that could guide doctors in better matching drugs to patients based on immune system ...
MIT Technology Review10d
The first trial of generative AI therapy shows it might help with depression
The evidence-backed model delivered impressive results, but it doesn’t validate the wave of AI therapy bots flooding the ...
Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure
Received positive feedback on New Drug Application submission via the 505(b)(2) pathway-Company leveraging existing human pharmacokinetic data ...
Fierce Healthcare10d
Evernorth expands coverage of NeuroStar depression therapy to adolescents
Cigna's Evernorth unit is expanding coverage for Neuronetics' therapy for depression to adolescents. | Cigna's Evernorth unit ...
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
The expansion is effective immediately, nearly one year after NeuroStar ® Advanced Therapy received FDA clearance as the first first-line add-on treatment for adolescents aged 15-21 with MDD. In the ...